Trial | NCT01682200  Report issue

Title

Clinical Trial on the Effects and Side Effects of ProOxy in the Treatment of Acne
An Open Label Pilot Clinical Trial on the Efficacy and Safety of ProOxy Facial Spray (Topical 15% Oxygen Solution) in the Treatment of Moderate Facial Acne Vulgaris Among Filipino Patients

  • Phase

    Phase 1

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Intervention/Treatment

    oxygen ...

  • Study Participants

    50
This study was conducted to determine the effects and side effects of ProOxy facial spray in the treatment of acne.
A study on the effects and side effects of ProOxy facial spray was done. Sixty people were selected and approved to participate in this study. Pictures of the face (frontal,left side and right side) were taken upon acceptance, during and after treatment at 4,8 and 12 weeks intervals.
Study Started
Oct 31
2009
Primary Completion
Mar 31
2010
Study Completion
Sep 30
2011
Last Update
Sep 10
2012
Estimate

Drug ProOxy

Clean the face with ProOxy facial wash before spraying ProOxy on the face enough to wet it twice daily, upon waking up and before bedtime.

  • Other names: 15% Oxygen solution spray

ProOxy, Effects and Side Effects in treating acne Experimental

Patients are instructed to clean the face with ProOxy facial cleanser and then spray on the face wet enough but not dripping twice daily (upon waking up and before bedtime) for 3 months.

Criteria 

Inclusion Criteria:

patients with acne on their faces only
patients who are at least 18 years of age
patients who have normal and disease free skin at the dorsal surface of the upper arm.
patients who are willing to follow instructions on both the Patch Test Part one and Part Two procedures and to follow scheduled visits.

Exclusion Criteria

patients with systemic illnesses(such as but not limited to heart disease, hypertension, diabetes, cancer, liver disease, kidney disease)
patients with very dark skin color, Fitzpatrick skin type V-VI, who are prone to post=inflammatory hyperpigmentation.
patients with intake of oral medications including glucocorticoids or any immuno-suppressants or who have undergone ultraviolet phototherapy for the past 2 weeks prior to the patch test.
patients with history of contact dermatitis, dermatographism or anaphylaxis.
patients with history of eczematous and inflammatory dermatitis, seborrheic dermatitis and psoriasis.
No Results Posted